Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedJan 26, 2022
DataAggregated Company Financials
  • 7D0.9%
  • 3M-8.4%
  • 1Y-17.2%
  • YTD-5.3%

Over the last 7 days, the Pharma industry has remained flat, although notably Nippon Shinyaku gained 3.4%. Unfortunately though, the industry is down 17% over the past 12 months.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 26 Jan 2022JP¥33.0tJP¥12.5tJP¥1.6t17.3x
Fri, 24 Dec 2021JP¥34.3tJP¥12.5tJP¥1.6t18x
Sun, 21 Nov 2021JP¥35.5tJP¥12.5tJP¥1.6t18.9x
Tue, 19 Oct 2021JP¥36.1tJP¥12.2tJP¥1.5t18.3x
Thu, 16 Sep 2021JP¥37.8tJP¥12.3tJP¥1.5t18.5x
Sat, 14 Aug 2021JP¥35.6tJP¥12.3tJP¥1.5t17.3x
Wed, 09 Jun 2021JP¥35.3tJP¥11.9tJP¥1.4t16.9x
Tue, 02 Mar 2021JP¥36.4tJP¥12.0tJP¥1.3t21.9x
Fri, 04 Dec 2020JP¥38.3tJP¥12.0tJP¥1.2t24.7x
Mon, 07 Sep 2020JP¥38.2tJP¥12.0tJP¥1.3t24.6x
Sun, 31 May 2020JP¥40.8tJP¥12.0tJP¥1.2t23.6x
Wed, 04 Mar 2020JP¥33.3tJP¥11.9tJP¥1.2t20.2x
Sat, 07 Dec 2019JP¥35.2tJP¥11.5tJP¥1.2t20.5x
Tue, 10 Sep 2019JP¥29.9tJP¥11.0tJP¥1.2t18.7x
Mon, 03 Jun 2019JP¥28.8tJP¥10.5tJP¥1.2t18.6x
Thu, 07 Mar 2019JP¥32.7tJP¥10.1tJP¥1.1t22.7x
PE Ratio


Total Market Cap: JP¥30.6tTotal Earnings: JP¥1.1tTotal Revenue: JP¥10.1t0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 20.4x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 13% per year over the last three years, and revenues for these companies have grown 7.4% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Pharma industry?


Industry PE: Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 20.4x. This is likely because analysts are expecting annual earnings growth of 12%, which is higher than its past year's earnings growth of 8.3% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 12% over the next 5 years. This is better than it's past earnings growth rate of 8.3% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4516 Nippon ShinyakuJP¥7.67k3.4%
4519 Chugai PharmaceuticalJP¥3.70k0.2%
4581 Taisho Pharmaceutical HoldingsJP¥5.51k2.8%
4536 Santen PharmaceuticalJP¥1.32k1.5%
4528 Ono PharmaceuticalJP¥2.73k0.4%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News